181 related articles for article (PubMed ID: 31949480)
1. A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis.
Yu X; Wang R; Han C; Wang Z; Jin X
J Cancer; 2020; 11(4):781-787. PubMed ID: 31949480
[TBL] [Abstract][Full Text] [Related]
2. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of long non-coding RNA H19, UCA1, and HOTAIR as promising biomarkers in human bladder cancer.
Wang W; Yin Z
Int J Clin Exp Pathol; 2017; 10(12):11659-11665. PubMed ID: 31966524
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of long non-coding RNA-based biomarkers in the urinary sediment and urinary exosomes for non-invasive diagnosis of bladder cancer.
Qiu T; Xue M; Li X; Li F; Liu S; Yao C; Chen W
Mol Omics; 2022 Dec; 18(10):938-947. PubMed ID: 36164958
[TBL] [Abstract][Full Text] [Related]
5. The long noncoding RNA SUMO1P3 as urinary biomarker for monitoring bladder cancer progression.
Galbiati S; Bettiga A; Colciago G; Senti C; Trevisani F; Villa G; Marzinotto I; Ghidini M; Passalacqua R; Montorsi F; Salonia A; Vago R
Front Oncol; 2024; 14():1325157. PubMed ID: 38846969
[TBL] [Abstract][Full Text] [Related]
6. Circulating lncRNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis based on 15 published articles.
Wang J; Gao Y; Wang X; Gao Y; Li L; Zhang J; Zhang L; Che F
Int J Biol Markers; 2020 Jun; 35(2):40-48. PubMed ID: 32460591
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C
J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945
[TBL] [Abstract][Full Text] [Related]
8. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
[TBL] [Abstract][Full Text] [Related]
9. Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence.
Pan J; Xie X; Li H; Li Z; Ren C; Ming L
Int J Clin Exp Pathol; 2019; 12(8):2951-2958. PubMed ID: 31934131
[TBL] [Abstract][Full Text] [Related]
10. Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer.
Yazarlou F; Modarressi MH; Mowla SJ; Oskooei VK; Motevaseli E; Tooli LF; Nekoohesh L; Eghbali M; Ghafouri-Fard S; Afsharpad M
Cancer Manag Res; 2018; 10():6357-6365. PubMed ID: 30568497
[TBL] [Abstract][Full Text] [Related]
11. Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing.
Bian B; Li L; Ke X; Chen H; Liu Y; Zheng N; Zheng Y; Ma Y; Zhou Y; Yang J; Xiao L; Shen L
Front Oncol; 2022; 12():976329. PubMed ID: 36119544
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.
Zheng R; Liang J; Lu J; Li S; Zhang G; Wang X; Liu M; Wang W; Chu H; Tao G; Zhao Q; Wang M; Du M; Qiang F; Zhang Z
Gastric Cancer; 2019 Jul; 22(4):731-741. PubMed ID: 30603909
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer.
Zhang K; Shi H; Xi H; Wu X; Cui J; Gao Y; Liang W; Hu C; Liu Y; Li J; Wang N; Wei B; Chen L
Theranostics; 2017; 7(1):213-227. PubMed ID: 28042329
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
16. Differential Plasma Expression Profiles of Long Non-Coding RNAs Reveal Potential Biomarkers for Systemic Lupus Erythematosus.
Wu GC; Hu Y; Guan SY; Ye DQ; Pan HF
Biomolecules; 2019 May; 9(6):. PubMed ID: 31141998
[TBL] [Abstract][Full Text] [Related]
17. Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis.
Gharib E; Anaraki F; Baghdar K; Ghavidel P; Sadeghi H; Nasrabadi PN; Peyravian N; Aghdaei HA; Zali MR; Mojarad EN
J Cell Biochem; 2019 Sep; 120(9):14780-14790. PubMed ID: 30993787
[TBL] [Abstract][Full Text] [Related]
18. A new biomarker panel of ultraconserved long non-coding RNAs for bladder cancer prognosis by a machine learning based methodology.
Ciaramella A; Di Nardo E; Terracciano D; Conte L; Febbraio F; Cimmino A
BMC Bioinformatics; 2023 Mar; 23(Suppl 6):569. PubMed ID: 36879192
[TBL] [Abstract][Full Text] [Related]
19. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
Eissa S; Matboli M; Essawy NO; Kotb YM
Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
[TBL] [Abstract][Full Text] [Related]
20. Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
Dudek AM; Boer SJ; Boon N; Witjes JA; Kiemeney LALM; Verhaegh GW
Oncotarget; 2017 May; 8(21):34442-34452. PubMed ID: 28415801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
